Skip to main content
Erschienen in: Dermatology and Therapy 1/2019

Open Access 26.11.2018 | Case Report

A Case Report of Scrotal Rejuvenation: Laser Treatment of Angiokeratomas of the Scrotum

verfasst von: Philip R. Cohen

Erschienen in: Dermatology and Therapy | Ausgabe 1/2019

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Scrotal rejuvenation encompasses not only the functional quality but also the aesthetic appearance of the scrotum. It includes medical therapy and procedural interventions to improve scrotal conditions that require morphologic restoration and/or aesthetic alteration. Rejuvenation of the scrotum may be appropriate for aging-related and non-aging-related changes concerning the hair (alopecia and hypertrichosis), the morphology (laxity and wrinkles), and/or the vascularity (angiokeratoma) of the scrotum. Angiokeratomas—typically small, asymptomatic, purple papules—may occur on the scrotum. However, these benign vascular lesions may be of cosmetic concern to the affected individuals; in addition, the angiokeratomas can become an issue of medical importance if they begin to bleed. Multiple locally destructive modalities are available for the treatment of scrotal angiokeratomas; indeed, several lasers have effectively been used to treat angiokeratomas of the scrotum. A 70-year-old man with numerous scrotal angiokeratomas experienced scrotal bleeding in the absence of prior trauma to the area or sexual activity. He presented for treatment to prevent future episodes of spontaneous bleeding from his scrotal angiokeratomas, but he also had not liked the aesthetic appearance of the previously asymptomatic angiokeratomas on his scrotum. His angiokeratomas were successfully treated with three sequential 532-nm potassium titanyl phosphate (KTP) laser sessions, which led to not only functional but also cosmetic improvement of his scrotum. In conclusion, men can develop scrotal changes due to either intrinsic (aging) or extrinsic (trauma) causes, but nonsurgical interventions and surgical procedures are available for the management of these conditions in individuals who desire to rejuvenate their scrotum.
Hinweise

Enhanced Digital Features

To view enhanced digital features for this article go to https://​doi.​org/​10.​6084/​m9.​figshare.​7314353.

Introduction

Scrotal rejuvenation refers to medical and cosmetic conditions of the scrotum that can appear with aging and may be amenable to medical treatment and/or surgical intervention [1]. Angiokeratomas of the scrotum present as small purple to red papules that are usually asymptomatic, although spontaneous bleeding occurs in some men [27]. A man with bleeding scrotal angiokeratomas that were successfully treated with only a 532-nm potassium titanyl phosphate (KTP) laser is described here. While the lesions had previously been asymptomatic, he did not like their aesthetic appearance on his scrotum but had not realized that there were potential interventions that could be used to resolve the angiokeratomas. To the author’s knowledge, this is the first case report of a 532-nm KTP laser being used as monotherapy for this purpose. Informed consent was obtained from the participant for inclusion in the study. The patient also signed a consent form providing permission to include relevant clinical photographs in this article.

Case Report

A 70-year-old man presented for evaluation of multiple lesions that had been present on his scrotum for more than three decades. The lesions had been asymptomatic, but he was unhappy with their appearance. Earlier that day, one of the lesions had bled; there had been no prior trauma or sexual activity. He compressed the site and the bleeding ceased.
Cutaneous examination showed more than 50 purple papules 2–3 mm in size on each side of his scrotum (Fig. 1). All of the lesions were painless. There was no evidence of varicocele, testicular tumor, or inguinal hernia. Correlation of the clinical presentation and lesion morphology established a diagnosis of angiokeratomas of the scrotum.
In order to prevent future episodes of spontaneous bleeding, the patient decided to have laser treatment of his scrotal angiokeratomas. A 532-nm KTP frequency-doubled neodymium-doped yttrium aluminum garnet (Nd:YAG) laser (Excel V; Brisbane, CA, USA) was applied in three monthly treatments. The treatment parameters were as follows: wavelength 532 nm, fluence 11 J/cm2, spot size 3 mm, pulse duration 10 ms, cooling 10 ºC, and an endpoint of vessel darkening.
He received 215 pulses during his first treatment. His second and third treatments were performed one and two months after the initial session, respectively. The same parameters were used during the subsequent sessions, during which he received 201 pulses and 225 pulses, respectively. He tolerated the procedure well, with minimal redness or swelling and no bruising.
A follow-up cutaneous examination performed 3 weeks after his third laser treatment showed a significant decrease in both the number and the size of the angiokeratomas on his scrotum (Fig. 2). He was extremely pleased with the cosmetic appearance. He has had no further episodes of scrotal bleeding.

Discussion

Genital rejuvenation includes vaginal rejuvenation and scrotal rejuvenation [8]. Rejuvenation of the scrotum includes not only the management of vascular lesions (such as angiokeratomas) but also alterations to the hair (alopecia and hypertrichosis) and morphology (laxity and wrinkles) [1]. Medical and surgical interventions can be used to potentially treat these conditions of the scrotum [1, 8].
Angiokeratomas are benign vascular lesions (Table 1) [131]. The incidence of scrotal angiokeratomas remains to be determined. Local destructive methods, including lasers (Table 2) [13, 14, 2231], have traditionally been used to treat angiokeratoma of the scrotum [14, 6, 1214, 2131].
Table 1
Features of angiokeratomas of the scrotum
History and nomenclature [1116]
 Scrotal angiokeratomas, also known as Fordyce angiokeratomas, were initially described on the scrotum of a 60-year-old man by John Addison Fordyce in 1896
 Angiokeratomas of Fordyce also refer to genital angiokeratomas at other sites such as the glans and shaft of the penis in men and the vulva in women
Prevalence [9, 10, 13, 14]
 They were noted not only in young men who underwent intense physical activity, but also in debilitated older men
 Their prevalence has been described to be 0.6% in 16- to 20-year-old men, with the rate increasing to 16.6% in men over 70 years of age
Clinical presentation [5, 7, 13]
 Angiokeratomas of the scrotum are usually asymptomatic
 Often the patient is unaware of their presence, and is initially informed of their presence during a total body skin examination
 They are occasionally discovered by the individual’s sexual partner, and the man presents for evaluation concerned that the vascular lesions represent a sexually transmitted disease
Morphology [13, 14, 17]
 They typically appear as multiple dome-shaped papules, with or without overlying scale
 They are usually small and range in diameter from 1 or 2 mm to 3 or 4 mm, but they can be as large as 6 mm
 They are often dark red or purple, but they may appear blue or black
Associated conditions [9, 10, 14, 1720]
 Concurrent varicoceles have been described
 Less commonly, they elicit sensations of heaviness and tension
 Accompanying irritation may also occur
 Infrequently, excoriations with impetiginization or bacterial infection may be present
 Acute onset of scrotal bleeding may require urgent treatment; often there is no antecedent history of trauma and the bleeding is unprovoked, but bleeding may follow sexual intercourse
Treatment [18, 1214, 2131]
 Immediate interventions for bleeding: cauterization using a silver nitrate stick, electrofulguration, electrocautery, and/or tamponade by tight gauze binding of the scrotum
 Methods for asymptomatic angiokeratomas: cryotherapy with liquid nitrogen, electrosurgery (such as electrocautery and electrofulguration), excision, lasers, and sclerotherapy
Table 2
Laser treatment of angiokeratoma of the scrotum
Wavelength (nm)
Laser
Reference(s)
 
Argon
[23]
532a
KTP
[24], CR
532
Nd:YAG
[25]
578
Copper vapor
[26]
585
Pulsed dye laser
[27]
595
Pulsed dye laser
[13, 14]
940
Diode
[28]
1064
Nd:YAG
[13, 2931]
CR current report, KTP potassium titanyl phosphate, Nd:YAG neodymium-doped yttrium aluminum garnet, nm nanometers
aTo the author’s knowledge, this is the first case report of a 532-nm KTP laser being used as monotherapy for the treatment of scrotal angiokeratomas. In a previously reported patient, a 10,600-nm ablative carbon dioxide laser was used to remove the epidermal hyperkeratosis prior to treatment of the angiokeratomas with the KTP laser [24]
The reported patient had not been pleased with the aesthetic appearance of the angiokeratomas on his scrotum, but was unaware that cosmetic intervention to remove angiokeratomas was available. Indeed, his scrotal angiokeratomas were successfully treated with a 532-nm KTP frequency-doubled Nd:YAG laser. The 532-nm wavelength is produced by placing a KTP crystal in the path of a 1064-nm Nd:YAG laser beam, which results in a frequency-doubled 532-nm wavelength, which is absorbed well by oxyhemoglobin. The laser allows contact cooling through a sapphire window [22, 32].
The 532-nm KTP laser has been used in the management of acne vulgaris [33], rosacea [34], and skin rejuvenation [35]. In addition, the 532-nm KTP laser has been used to treat angiokeratomas of not only the scrotum (in combination with a 10,600-nm ablative carbon dioxide laser to remove the epidermal hyperkeratosis) [24], but also the glans penis (in combination with a 2,940-nm ablative Er:YAG laser to eliminate hyperkeratosis of the epidermis) [36]. Finally, the 532-nm KTP laser has successfully treated nongenital angiokeratoma [37] and other vascular lesions [32, 34, 3841].

Conclusion

Scrotal rejuvenation may be appropriate not only for aesthetic concerns but also for conditions that may require functional restoration. Changes that are either aging-related or non-aging-related may result in issues concerning the hair, the morphology, and/or the vascularity of the scrotum. Medical therapy and procedural interventions may be appropriate for men desiring rejuvenation of their scrotum.
Angiokeratomas are benign vascular lesions. Although they are usually asymptomatic, they may be of either cosmetic concern and/or medical importance (if bleeding) to affected individuals. Several lasers have effectively been used to treat angiokeratomas of the scrotum.
Successful management of a man’s spontaneously bleeding scrotal angiokeratomas with three sequential 532-nm KTP laser treatments provided not only functional but also aesthetic improvement of his scrotum. To the author’s knowledge, this is the first case report of a 532-nm KTP laser being used as monotherapy for this purpose. Based on this case report of the clinical success of using the 532-nm KTP laser to treat angiokeratomas of the scrotum and the patient’s satisfaction, it is reasonable to suggest that this laser may have potential for the treatment of men with either bleeding or asymptomatic scrotal angiokeratomas.
In conclusion, either intrinsic (aging) or extrinsic (trauma) causes can result in men developing scrotal changes. There are nonsurgical interventions and surgical procedures available for the management of the conditions associated with these scrotal changes for men who desire to rejuvenate their scrotum.

Acknowledgments

I thank the participant in the study.

Funding

No funding or sponsorship was received for this study. The article processing charges were waived by the journal for the publication of this article.

Authorship

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published. The author is fully responsible for all content and received no financial support or any other form of compensation related to the development of this manuscript.

Disclosures

Philip R. Cohen has nothing to disclose with regards to the publication of this article.

Compliance with Ethics Guidelines

Informed consent was obtained from the participant for their inclusion in the study. The patient also signed a consent form providing permission to include clinical photographs in this article.

Open Access

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://​creativecommons.​org/​licenses/​by-nc/​4.​0/​), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Literatur
2.
3.
Zurück zum Zitat Parrotte DM. Angiokeratoma: a cause of scrotal bleeding. South Med J. 1985;78:487–8.CrossRef Parrotte DM. Angiokeratoma: a cause of scrotal bleeding. South Med J. 1985;78:487–8.CrossRef
4.
Zurück zum Zitat Taniguchi S, Inoue A, Hamada T. Angiokeratoma of Fordyce: a cause of scrotal bleeding. Br J Urol. 1994;73:589–90.CrossRef Taniguchi S, Inoue A, Hamada T. Angiokeratoma of Fordyce: a cause of scrotal bleeding. Br J Urol. 1994;73:589–90.CrossRef
5.
Zurück zum Zitat Hisa T, Taniguchi S, Goto Y, Teramae H, Osato K, Kakudo K, Takigawa M. Scrotal angiokeratoma in a young man. Act Derm Venereol. 1996;76:248–9. Hisa T, Taniguchi S, Goto Y, Teramae H, Osato K, Kakudo K, Takigawa M. Scrotal angiokeratoma in a young man. Act Derm Venereol. 1996;76:248–9.
6.
Zurück zum Zitat Hoekx L, Wyndaele JJ. Angiokeratoma: a cause of scrotal bleeding. Acta Urol Belg. 1998;66:27–8.PubMed Hoekx L, Wyndaele JJ. Angiokeratoma: a cause of scrotal bleeding. Acta Urol Belg. 1998;66:27–8.PubMed
7.
Zurück zum Zitat Tickett R, Dowd H. Angiokeratoma of the scrotum: a case of scrotal bleeding. Emerg Med J. 2006;23(10):e57.CrossRef Tickett R, Dowd H. Angiokeratoma of the scrotum: a case of scrotal bleeding. Emerg Med J. 2006;23(10):e57.CrossRef
9.
Zurück zum Zitat Imperial R, Helwig EB. Angiokeratoma. A critical pathological study. Arch Dermatol. 1967;43:187–200. Imperial R, Helwig EB. Angiokeratoma. A critical pathological study. Arch Dermatol. 1967;43:187–200.
10.
Zurück zum Zitat Imperial R, Helwig EB. Angiokeratoma of the scrotum (Fordyce type). J Urol. 1967;98:379–87.CrossRef Imperial R, Helwig EB. Angiokeratoma of the scrotum (Fordyce type). J Urol. 1967;98:379–87.CrossRef
11.
Zurück zum Zitat Fordyce JA. Angiokeratoma of the scrotum. J Cutan Genitourin Dis. 1896;14:81–7. Fordyce JA. Angiokeratoma of the scrotum. J Cutan Genitourin Dis. 1896;14:81–7.
12.
Zurück zum Zitat Beutler BD, Cohen PR. Angiokeratoma of the glan penis. Skinmed. 2017;15(5):350–4. Beutler BD, Cohen PR. Angiokeratoma of the glan penis. Skinmed. 2017;15(5):350–4.
13.
Zurück zum Zitat Ibrahim SM. Pulsed dye laser versus long pulsed Nd:YAG laser in the treatment of angiokeratoma of Fordyce: a randomized, comparative, observer-blinded study. J Dermatol Treat. 2016;27:270–4.CrossRef Ibrahim SM. Pulsed dye laser versus long pulsed Nd:YAG laser in the treatment of angiokeratoma of Fordyce: a randomized, comparative, observer-blinded study. J Dermatol Treat. 2016;27:270–4.CrossRef
14.
Zurück zum Zitat Baumgartner J, Simaljakova M. Genital angiokeratomas of Fordyce 595-nm variable-pulsed pulsed dye laser treatment. J Cosmet Laser Ther. 2017;19:459–64.CrossRef Baumgartner J, Simaljakova M. Genital angiokeratomas of Fordyce 595-nm variable-pulsed pulsed dye laser treatment. J Cosmet Laser Ther. 2017;19:459–64.CrossRef
15.
Zurück zum Zitat Cohen PR, Young AW Jr, Tovell HM. Angiokeratoma of the vulva: diagnosis and review of the literature. Obstet Gynecol Surv. 1989;44:339–46.CrossRef Cohen PR, Young AW Jr, Tovell HM. Angiokeratoma of the vulva: diagnosis and review of the literature. Obstet Gynecol Surv. 1989;44:339–46.CrossRef
16.
Zurück zum Zitat Burnett CT, Kouba DJ. A rare case of congenital angiokeratoma of the glans penis treated using a 595-nm pulsed laser. Dermatol Surg. 2012;38:2028–30.CrossRef Burnett CT, Kouba DJ. A rare case of congenital angiokeratoma of the glans penis treated using a 595-nm pulsed laser. Dermatol Surg. 2012;38:2028–30.CrossRef
17.
Zurück zum Zitat Gioglio L, Porta C, Moroni M, Nastasi G, Gangarossa I. Scrotal angiokeratoma (Fordyce): histopathological and ultrastructural findings. Histol Histopathol. 1992;7:47–55.PubMed Gioglio L, Porta C, Moroni M, Nastasi G, Gangarossa I. Scrotal angiokeratoma (Fordyce): histopathological and ultrastructural findings. Histol Histopathol. 1992;7:47–55.PubMed
18.
Zurück zum Zitat Agger P, Osmundsen PE. Angiokeratoma of the scrotum (Fordyce). A case report on response to surgical treatment of varicocele. Acta Derm Venereol. 1970;50:221–4.PubMed Agger P, Osmundsen PE. Angiokeratoma of the scrotum (Fordyce). A case report on response to surgical treatment of varicocele. Acta Derm Venereol. 1970;50:221–4.PubMed
19.
Zurück zum Zitat Erkek E, Basar MM, Bagci Y, Karaduman A, Bilen CY, Gokoz A. Fordyce angiokeratoma as clues to local venous hypertension. Arch Dermatol. 2005;141:1325–6.CrossRef Erkek E, Basar MM, Bagci Y, Karaduman A, Bilen CY, Gokoz A. Fordyce angiokeratoma as clues to local venous hypertension. Arch Dermatol. 2005;141:1325–6.CrossRef
20.
Zurück zum Zitat Tromp EE, Kouwenhoven STP, Quint KD, Gmelig Meijling KA, Genders RE. Unilateral scrotal angiomas: an expression of underlying varicocele. Scand J Urol. 2015;50:88–9.CrossRef Tromp EE, Kouwenhoven STP, Quint KD, Gmelig Meijling KA, Genders RE. Unilateral scrotal angiomas: an expression of underlying varicocele. Scand J Urol. 2015;50:88–9.CrossRef
21.
Zurück zum Zitat Seo SH, Chin HW, Sung HW. Angiokeratoma of Fordyce treated with 0.5% ethanolamine oleate or 0.25% sodium tetradecyl sulfate. Dermatol Surg. 2010;36:1634–7.CrossRef Seo SH, Chin HW, Sung HW. Angiokeratoma of Fordyce treated with 0.5% ethanolamine oleate or 0.25% sodium tetradecyl sulfate. Dermatol Surg. 2010;36:1634–7.CrossRef
22.
Zurück zum Zitat Nguyen J, Chapman LW, Korta DZ, Zachary CB. Laser treatment of cutaneous angiokeratomas: a systematic review. Dermatol Ther. 2017;30(6):e12558 (Epub 2017 Nov 19).CrossRef Nguyen J, Chapman LW, Korta DZ, Zachary CB. Laser treatment of cutaneous angiokeratomas: a systematic review. Dermatol Ther. 2017;30(6):e12558 (Epub 2017 Nov 19).CrossRef
23.
Zurück zum Zitat Flores JT, Apfelberg DB, Maser MR, Lash H, White D. Angiokeratoma of Fordyce: successful treatment with the argon laser. Plast Reconstr Surg. 1984;74:835–8.CrossRef Flores JT, Apfelberg DB, Maser MR, Lash H, White D. Angiokeratoma of Fordyce: successful treatment with the argon laser. Plast Reconstr Surg. 1984;74:835–8.CrossRef
24.
Zurück zum Zitat Bechara FG, Altmeyer P, Jansen T. Unilateral angiokeratoma scroti: a rare manifestation of a vascular tumor. J Dermatol. 2004;31:39–41.CrossRef Bechara FG, Altmeyer P, Jansen T. Unilateral angiokeratoma scroti: a rare manifestation of a vascular tumor. J Dermatol. 2004;31:39–41.CrossRef
25.
Zurück zum Zitat Bechara FG, Huesmann M, Stucker M, Altmeher P, Jansen T. An exceptional localization of angiokeratoma of Fordyce on the glans penis. Dermatology. 2002;205:187–8.CrossRef Bechara FG, Huesmann M, Stucker M, Altmeher P, Jansen T. An exceptional localization of angiokeratoma of Fordyce on the glans penis. Dermatology. 2002;205:187–8.CrossRef
26.
Zurück zum Zitat Lapins J, Emtestam L, Marcusson JA. Angiokeratomas in Fabry’s disease and Fordyce diserase: successful treatment with copper vapour laser. Acta Derm Venereol. 1993;73:133–5. Lapins J, Emtestam L, Marcusson JA. Angiokeratomas in Fabry’s disease and Fordyce diserase: successful treatment with copper vapour laser. Acta Derm Venereol. 1993;73:133–5.
27.
Zurück zum Zitat Lapidoth M, Ad-El D, David M, Azaria R. Treatment of angiokeratoma of Fordyce with pulsed dye laser. Dermatol Surg. 2006;32:1147–50.PubMed Lapidoth M, Ad-El D, David M, Azaria R. Treatment of angiokeratoma of Fordyce with pulsed dye laser. Dermatol Surg. 2006;32:1147–50.PubMed
28.
Zurück zum Zitat Meissner M, Kaufmann R. Therapy for angiokeratoma of Fordyce with the 940-nm diode laser. Akteul Urol. 2012;43:121–2.CrossRef Meissner M, Kaufmann R. Therapy for angiokeratoma of Fordyce with the 940-nm diode laser. Akteul Urol. 2012;43:121–2.CrossRef
29.
Zurück zum Zitat Ozdemir M, Baysal I, Engin B, Ozdemir S. Treatment of angiokeratoma of Fordyce with long-pulsed neodymium-doped yttrium aluminum garnet laser. Dermatol Surg. 2009;35:92–7.PubMed Ozdemir M, Baysal I, Engin B, Ozdemir S. Treatment of angiokeratoma of Fordyce with long-pulsed neodymium-doped yttrium aluminum garnet laser. Dermatol Surg. 2009;35:92–7.PubMed
30.
Zurück zum Zitat Civas E, Koc E, Aksoy B, Aksoy HM. Report of two angiokeratomas of Fordyce cases treated with a 1064 nm long-pulsed Nd:YAG laser. Photodermatol Photoimmunol Photomed. 2009;25:166–8.CrossRef Civas E, Koc E, Aksoy B, Aksoy HM. Report of two angiokeratomas of Fordyce cases treated with a 1064 nm long-pulsed Nd:YAG laser. Photodermatol Photoimmunol Photomed. 2009;25:166–8.CrossRef
31.
Zurück zum Zitat Zeng Y, Zhan K, Xie WL, Lin QZ. Angiokeratoma of Fordyce response to long pulsed Nd:YAG laser treatment. Dermatol Ther (Heidl). 2016;29:48–51.CrossRef Zeng Y, Zhan K, Xie WL, Lin QZ. Angiokeratoma of Fordyce response to long pulsed Nd:YAG laser treatment. Dermatol Ther (Heidl). 2016;29:48–51.CrossRef
32.
Zurück zum Zitat Kearney TC, Tanzi E, Alster T. Comparison of 532 nm potassium titanyl phosphate laser and 595 nm pulsed dye laser in the treatment of erythematous surgical scars: a randomized, controlled, open-label study. Dermatol Surg. 2016;42:70–6.CrossRef Kearney TC, Tanzi E, Alster T. Comparison of 532 nm potassium titanyl phosphate laser and 595 nm pulsed dye laser in the treatment of erythematous surgical scars: a randomized, controlled, open-label study. Dermatol Surg. 2016;42:70–6.CrossRef
33.
Zurück zum Zitat Baugh WP, Kucaba WD. Nonablative phototherapy for acne vulgaris using the KTP 532-nm laser. Dermatol Surg. 2005;31:1290–6.CrossRef Baugh WP, Kucaba WD. Nonablative phototherapy for acne vulgaris using the KTP 532-nm laser. Dermatol Surg. 2005;31:1290–6.CrossRef
34.
Zurück zum Zitat Alexiades-Armenakas M. Excel V roundtable. J Drug Dermatol. 2013;12:1231-1234. Alexiades-Armenakas M. Excel V roundtable. J Drug Dermatol. 2013;12:1231-1234.
35.
Zurück zum Zitat Lee MW. Combination 532-nm and 1,064-nm lasers for noninvasive skin rejuvenation and toning. Arch Dermatol. 2003;139:1265–76.CrossRef Lee MW. Combination 532-nm and 1,064-nm lasers for noninvasive skin rejuvenation and toning. Arch Dermatol. 2003;139:1265–76.CrossRef
36.
Zurück zum Zitat Bechara FG, Jansen T, Wilmert M, Altmeyer P, Hoffmann K. Angiokeratoma Fordyce of the glans penis: combined treatment with erbium:YAG and 532 nm KTP (frequency doubled neodymium:YAG) laser. J Dermatol. 2004;31:943–5.CrossRef Bechara FG, Jansen T, Wilmert M, Altmeyer P, Hoffmann K. Angiokeratoma Fordyce of the glans penis: combined treatment with erbium:YAG and 532 nm KTP (frequency doubled neodymium:YAG) laser. J Dermatol. 2004;31:943–5.CrossRef
37.
Zurück zum Zitat Gorse SJ, James W, Murison MS. Successful treatment of angiokeratoma with potassium tritanyl phosphate laser. Br J Dermatol. 2004;150:620–2.CrossRef Gorse SJ, James W, Murison MS. Successful treatment of angiokeratoma with potassium tritanyl phosphate laser. Br J Dermatol. 2004;150:620–2.CrossRef
38.
Zurück zum Zitat Reddy KK, Brauer JA, Idriss MH, Anolik R, Bernstein L, Brightman L, Hale E, Karen J, Weiss E, Elston D, Geronemus RG. Treatment of port-wine stains with a short pulse width 532-nm Nd:YAG laser. J Drug Dermatol. 2013;12:66–71. Reddy KK, Brauer JA, Idriss MH, Anolik R, Bernstein L, Brightman L, Hale E, Karen J, Weiss E, Elston D, Geronemus RG. Treatment of port-wine stains with a short pulse width 532-nm Nd:YAG laser. J Drug Dermatol. 2013;12:66–71.
39.
Zurück zum Zitat Rho NK, Kim H, Kim HS. Successful treatment of angioma serpinginosum using a novel 532 nm potassium titanyl phosphate (KTP) laser. J Dermatol. 2014;41:996–8.PubMed Rho NK, Kim H, Kim HS. Successful treatment of angioma serpinginosum using a novel 532 nm potassium titanyl phosphate (KTP) laser. J Dermatol. 2014;41:996–8.PubMed
40.
Zurück zum Zitat Becher GL, Cameron H, Moseley H. Treatment of superficial vascular lesions using the KTP 532-nm laser. Dermatol Surg. 2005;31:1290–6.CrossRef Becher GL, Cameron H, Moseley H. Treatment of superficial vascular lesions using the KTP 532-nm laser. Dermatol Surg. 2005;31:1290–6.CrossRef
41.
Zurück zum Zitat Bernstein EF, Noyaner-Turley A, Renton B. Treatment of spider veins of the lower extremities with a novel 532 nm KTP laser. Lasers Surg Med. 2014;46:81–8.CrossRef Bernstein EF, Noyaner-Turley A, Renton B. Treatment of spider veins of the lower extremities with a novel 532 nm KTP laser. Lasers Surg Med. 2014;46:81–8.CrossRef
Metadaten
Titel
A Case Report of Scrotal Rejuvenation: Laser Treatment of Angiokeratomas of the Scrotum
verfasst von
Philip R. Cohen
Publikationsdatum
26.11.2018
Verlag
Springer Healthcare
Erschienen in
Dermatology and Therapy / Ausgabe 1/2019
Print ISSN: 2193-8210
Elektronische ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-018-0272-z

Weitere Artikel der Ausgabe 1/2019

Dermatology and Therapy 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.